Evidence map›Paper›PMID 27206766›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis.

Lin Ding, Tianju Liu, Zhe Wu, Biao Hu, Taku Nakashima, Matthew Ullenbruch, Francina Gonzalez De Los Santos, Sem H Phan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Amphiregulin and Fibrosis: Existing Evidence and Future Directions.International journal of molecular sciences · 2025
    Review
  3. The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Article
  5. Amphiregulin in Fibrotic Diseases and Cancer.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Amphiregulin-producing TThe journal of allergy and clinical immunology. Global · 2024
    Article
  12. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2024
    Article
  13. Article
  14. Review
  15. Immunology of human fibrosis.Nature immunology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lin DingDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Tianju LiuDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Zhe WuDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Biao HuDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0002-4691-6490
Taku NakashimaDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0002-0035-674X
Matthew UllenbruchDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Francina Gonzalez De Los SantosDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Sem H PhanDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109 shphan@umich.edu.
University of Michigan · US

Funding

MYOFIBROBLASTS IN PULMONARY FIBROSISR01HL052285 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 1994 to 2017
$5.4M
Resistin-like molecules in pulmonary fibrosisR01HL112880 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 2013 to 2016
$2.0M
NHLBI NIH HHS R01 HL052285NHLBI NIH HHS R01 HL112880
6 · The paper itself

Abstract

Amphiregulin (AREG), an epidermal growth factor receptor ligand, is implicated in tissue repair and fibrosis, but its cellular source and role in regeneration versus fibrosis remain unclear. In this study, we hypothesize that AREG induced in bone marrow-derived CD11c(+) cells is essential for pulmonary fibrosis. Thus, the objectives were to evaluate the importance and role of AREG in pulmonary fibrosis, identify the cellular source of AREG induction, and analyze its regulation of fibroblast function and activation. The results showed that lung AREG expression was significantly induced in bleomycin-induced pulmonary fibrosis. AREG deficiency in knockout mice significantly diminished pulmonary fibrosis. Analysis of AREG expression in major lung cell types revealed induction in fibrotic lungs predominantly occurred in CD11c(+) cells. Moreover, depletion of bone marrow-derived CD11c(+) cells suppressed both induction of lung AREG expression and pulmonary fibrosis. Conversely, adoptive transfer of bone marrow-derived CD11c(+) cells from bleomycin-treated donor mice exacerbated pulmonary fibrosis, but not if the donor cells were made AREG deficient prior to transfer. CD11c(+) cell-conditioned media or coculture stimulated fibroblast proliferation, activation, and myofibroblast differentiation in an AREG-dependent manner. Furthermore, recombinant AREG induced telomerase reverse transcriptase, which appeared to be essential for the proliferative effect. Finally, AREG significantly enhanced fibroblast motility, which was associated with increased expression of α6 integrin. These findings suggested that induced AREG specifically in recruited bone marrow-derived CD11c(+) cells promoted bleomycin-induced pulmonary fibrosis by activation of fibroblast telomerase reverse transcriptase-dependent proliferation, motility, and indirectly, myofibroblast differentiation.

Indexed as

AmphiregulinAnimalsAutocrine CommunicationBone Marrow CellsCD11c AntigenCell DifferentiationCells, CulturedCross-PrimingDendritic CellsFemaleLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutPulmonary FibrosisReceptor, Interferon alpha-betaAmphiregulinCD11c AntigenIfnar1 protein, mouseLipopolysaccharidesReceptor, Interferon alpha-betaSTAT2 Transcription FactorToll-Like Receptors

Identifiers

PMID27206766
PMCPMC4912903
OpenAlexW2405984650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.